Registration
Advertiser Disclosure

Biotechnology, Healthcare, and Research by BridgeBio Pharma

AI skepticism from BridgeBio Pharma CEO seen as BBIO stock holds near weekly highs
  • Parshwa Turakhiya
  • 7 hours ago
AI skepticism from BridgeBio Pharma CEO seen as BBIO stock holds near weekly highs
BridgeBio Pharma CEO Neil Kumar pushed back on artificial intelligence optimism during a discussion with Bloomberg at the Milken Institute Global Conference.Kumar said that AI cannot compress a ...
BridgeBio Pharma unveils gene-based rare disease push as BBIO bounces above support
  • Ciaran Ryan
  • Yesterday
BridgeBio Pharma unveils gene-based rare disease push as BBIO bounces above support
BridgeBio Pharma stated that its drug programs start by identifying the gene that is broken, rather than with a molecule.The company said this approach leads to clearer biology and clearer ...
BridgeBio Pharma stock falls near weekly lows amid ongoing selling and limited rebound potential
  • Ciaran Ryan
  • 03.06.2026
BridgeBio Pharma stock falls near weekly lows amid ongoing selling and limited rebound potential
BridgeBio Pharma reported that Arielle and her family received a diagnosis related to her lifelong need to manage low calcium levels.Arielle grew up eating ice cream for breakfast as part of ...
BridgeBio Pharma stock extends weekly slide with sellers in control after Denmark conference
  • Ezequiel Gomes
  • 03.06.2026
BridgeBio Pharma stock extends weekly slide with sellers in control after Denmark conference
BridgeBio Pharma supported the CureLGMD2i Foundation European LGMD2I/R9 Patient & Family Conference in Denmark.More than 20 countries participated in the event, which focused on community, ...
BridgeBio Pharma stock drops 3.97% as NDA filed with FDA for BBP-418 therapy
  • Daria Chernytska
  • 30.03.2026
BridgeBio Pharma stock drops 3.97% as NDA filed with FDA for BBP-418 therapy
BridgeBio Pharma has submitted a New Drug Application to the FDA for BBP-418 for individuals living with LGMD2I/R9.If approved, this would become the first therapy for this community and ...
BridgeBio Pharma stock price forecast: mixed signals as BBIO retreats 3.97% toward key support
  • Igor Krasulya
  • 29.03.2026
BridgeBio Pharma stock price forecast: mixed signals as BBIO retreats 3.97% toward key support
BridgeBio Pharma is raising awareness about ATTR-CM during Amyloidosis Awareness Month.The company states that recognizing the signs of ATTR-CM can help support earlier diagnosis and informed ...
BridgeBio Pharma launches initiative to define age-specific pathways for FGFR3 testing
  • Artem Shendetskii
  • 19.03.2026
BridgeBio Pharma launches initiative to define age-specific pathways for FGFR3 testing
BridgeBio Pharma brought together a multidisciplinary panel of experts to address longstanding delays in diagnosing hypochondroplasia in children. The company coordinated efforts to establish ...
BridgeBio Pharma supports LGMD Family Guide distribution at conference
  • Artem Shendetskii
  • 10.02.2026
BridgeBio Pharma supports LGMD Family Guide distribution at conference
BridgeBio Pharma is actively participating in the distribution of the LGMD Family Guide, a valuable resource for individuals and families affected by limb-girdle muscular dystrophy (LGMD), at the ...
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR